Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TA-CIN |
| Trade Name | |
| Synonyms | HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN |
| Drug Descriptions |
TA-CIN is a cancer vaccine comprising a fusion protein of HPV16 L2, E6, and E7, which potentially increases immune response to HPV-related tumors (PMID: 19095032, PMID: 15131030). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C121648 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| pNGVL4a-hCRT-E6E7L2 + TA-CIN | TA-CIN pNGVL4a-hCRT-E6E7L2 | 0 | 0 |
| TA-CIN | TA-CIN | 0 | 2 |